Critical Care

official impact factor 4.60

Open Access Research

Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model

Heinz R Redl*, Ulrich Martin, Anna Khadem, Linda E Pelinka and Martijn van Griensven

Critical Care 2005, 9:R735-R744 doi:10.1186/cc3825

No comments have yet been made on this article.

Post a comment